Hypoallergenicity of A Whey-Based, Extensively Hydrolysed Infant Formula Containing Two Human Milk Oligosaccharides
Abstract:
To determine whether an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) was tolerated by infants with cow’s milk protein allergy (CMPA).
Methods:
A whey-based EHF (Test formula) containing 2′fucosyl-lactose (2′FL) and lacto-N-neotetraose (LNnT) was assessed for clinical hypoallergenicity and safety. The Control formula was a cur...
Tags
This article's user rating is
Authors
Professor Anna Nowak-Wegrzyn
Dr Laura Czerkies
Kemuel Reyes
Dr Barbara Collins
Dr Ralf G. Heine
Related case studies
Professor Antonella Muraro
Professor Yvan Vandenplas
Rachel DeBoer (RD)
Specialist Paediatric Allergy Dietitian, Guy’s and St Thomas’ Hospital
Related Content
Nestlé Nutrition Institute
Related Products
